CryoLife, Inc., a company based outside of Atlanta, Georgia, announced this week that it has received the European CE Mark for the E-vita Open NEO, a hybrid stent graft system for the treatment of aortic arch disease.
Aortic arch disease encompasses both aortic aneurysms and aortic dissections, which occur suddenly and could be fatal. Acco (Read more...)